{"id":15900,"date":"2025-10-23T18:15:15","date_gmt":"2025-10-23T12:45:15","guid":{"rendered":"https:\/\/trending.niftytrader.in\/?p=15900"},"modified":"2025-10-23T18:43:29","modified_gmt":"2025-10-23T13:13:29","slug":"orkla-india-ipo-launch-october","status":"publish","type":"post","link":"https:\/\/www.niftytrader.in\/markets\/orkla-india-ipo-launch-october\/","title":{"rendered":"Orkla India to Launch \u20b91,660 Crore IPO Between October 29 and 31"},"content":{"rendered":"

Orkla India Limited, the Indian arm of Norway\u2019s Orkla ASA and parent company of household brands like MTR Foods, Eastern Condiments, and Rasoi Magic, is all set to launch its initial public offering (IPO) between October 29 and October 31, according to multiple sources cited by Moneycontrol<\/em>.<\/p>\n

The anchor book for the issue is expected to open on October 28, while the red herring prospectus will be filed shortly, industry sources confirmed.<\/p>\n

IPO Valuation and Structure<\/h2>\n

At the upper end of the price band, the post-money valuation of Orkla India\u2019s IPO is estimated to be around \u20b910,000 crore ($1.13 billion). The issue will be a complete offer for sale (OFS) of 2.28 crore equity shares, translating to a 16.6% stake dilution.<\/p>\n

The issue size is expected to be around \u20b91,660 crore, with the sale including stakes from promoter Orkla Asia Pacific Pte Ltd and shareholders Navas Meeran and Feroz Meeran.<\/p>\n

\n

\u201cThe IPO, fully structured as an OFS, means that no fresh funds will go to the company. The entire proceeds will go to selling shareholders,\u201d<\/em> sources told Moneycontrol<\/em>.<\/p>\n<\/blockquote>\n

As of now, Orkla Asia Pacific and Orkla ASA together hold 90% of Orkla India, while Navas and Feroz Meeran each hold 5% stakes.<\/p>\n

Also Read<\/strong>: Scammers Use Deepfakes and Fake Apps to Target Investors<\/a><\/em><\/p>\n

Regulatory Approvals and Lead Managers<\/h2>\n

Orkla India had received SEBI\u2019s approval on September 15 after filing its draft red herring prospectus (DRHP) in July 2025.<\/p>\n

The book-running lead managers to the issue are:<\/p>\n